Back to competency map

Clinical competency

Inform participants of new safety-relevant findings

Investigators have a continuing duty to inform participants about new findings regarding LSD or LSD-assisted therapy that emerge during the study. This reflects an ongoing consent responsibility rather than a one-time disclosure.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

1

Classification

Protocol families

LSD

Source quality

SOP / guidebook

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Informed Consent / trial document for LDA-1: LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life-threatening diseases

    LSDEvidence score: 70
    Gasser et al., 2014Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth